Vitamin D and Demyelinating Diseases: Neuromyelitis Optica (NMO) and Multiple Sclerosis (MS)

Overview

Journal Autoimmune Dis

Publisher Wiley

Date 2020 May 7

PMID 32373353

Citations 7

Authors

Cady Rodney

Sherriann Rodney

Richard M Millis

Affiliations

Soon will be listed here.

Abstract

Vitamin D deficiency is prevalent in all ages regardless of climate or geographical location and evidence is emerging that the incidence of autoimmune diseases is increasing worldwide. Women make up a large proportion of autoimmune disease diagnoses, underscoring the importance of fully elucidating the complex synergistic relationships between estrogens and vitamin D. Vitamin D receptor-activating drugs appear to enhance remyelination in patients diagnosed with multiple sclerosis (MS) and other demyelinating diseases such as neuromyelitis optica (NMO). This review is intended to update health practitioners about the potential role of vitamin D deficiency demyelination and to motivate future research on dietary recommendations for vitamin D in preventing and treating demyel1nating diseases.

Citing Articles

Alzheimer's disease (AD) in multiple sclerosis (MS): A systematic review of published cases, mechanistic links between AD and MS, and possible clinical evaluation of AD in MS.

Cottrill R, Ekanayake A, Grove C, Peiris S, Corbett N, Ahmed B J Alzheimers Dis Rep. 2025; 9:25424823251316134.

PMID: 40034519 PMC: 11864252. DOI: 10.1177/25424823251316134.

Vitamin D Deficiency-Associated Neuropathic Pain Examined in a Chronic Pain Management Program.

Li M, Lai K Perm J. 2024; 28(3):180-184.

PMID: 38980764 PMC: 11404642. DOI: 10.7812/TPP/24.026.

Neuromyelitis optica spectrum disorders relapses and seasonal influence in an equatorial country cohort.

Restrepo-Aristizabal C, Giraldo L, Franco C, Tobon J, Ascencio J, Torres-Bustamante M Rev Neurol. 2024; 78(5):127-133.

PMID: 38416504 PMC: 11064945. DOI: 10.33588/rn.7805.2023286.

Socioeconomic, Clinical, and Laboratory Parameters Differentiating Pediatric Patients With MOG Antibody-Associated Disease and Multiple Sclerosis.

Florenzo B, Brenton J J Child Neurol. 2023; 38(3-4):178-185.

PMID: 37122175 PMC: 10213154. DOI: 10.1177/08830738231170290.

Incidence of neuromyelitis optica spectrum disorders in China: a large cohort study using claim data.

Wu Y, Yang M, Gao P, Wang Z, Wu J, Wang J BMJ Open. 2022; 12(1):e048942.

PMID: 35105613 PMC: 8804634. DOI: 10.1136/bmjopen-2021-048942.

References

Min J, Waters P, Vincent A, Cho H, Joo B, Woo S . Low levels of vitamin D in neuromyelitis optica spectrum disorder: association with disease disability. PLoS One. 2014; 9(9):e107274. PMC: 4161425. DOI: 10.1371/journal.pone.0107274. View

Ramasamy A, Trabzuni D, Forabosco P, Smith C, Walker R, Dillman A . Genetic evidence for a pathogenic role for the vitamin D3 metabolizing enzyme in multiple sclerosis. Mult Scler Relat Disord. 2015; 3(2):211-219. PMC: 4278441. DOI: 10.1016/j.msard.2013.08.009. View

Smolders J, Peelen E, Thewissen M, Menheere P, Cohen Tervaert J, Hupperts R . The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev. 2009; 8(7):621-6. DOI: 10.1016/j.autrev.2009.02.009. View

Ramagopalan S, Sadovnick A . Epidemiology of multiple sclerosis. Neurol Clin. 2011; 29(2):207-17. DOI: 10.1016/j.ncl.2010.12.010. View

Wang T, Zhang F, Richards J, Kestenbaum B, van Meurs J, Berry D . Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010; 376(9736):180-8. PMC: 3086761. DOI: 10.1016/S0140-6736(10)60588-0. View

Jones G . Pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008; 88(2):582S-586S. DOI: 10.1093/ajcn/88.2.582S. View

Yin J, Valin K, Dixon M, Leavenworth J . The Role of Microglia and Macrophages in CNS Homeostasis, Autoimmunity, and Cancer. J Immunol Res. 2018; 2017:5150678. PMC: 5749282. DOI: 10.1155/2017/5150678. View

Spanier J, Nashold F, Mayne C, Nelson C, Hayes C . Vitamin D and estrogen synergy in Vdr-expressing CD4(+) T cells is essential to induce Helios(+)FoxP3(+) T cells and prevent autoimmune demyelinating disease. J Neuroimmunol. 2015; 286:48-58. DOI: 10.1016/j.jneuroim.2015.06.015. View

Mokry L, Ross S, Ahmad O, Forgetta V, Davey Smith G, Goltzman D . Correction: Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study. PLoS Med. 2016; 13(3):e1001981. PMC: 4775038. DOI: 10.1371/journal.pmed.1001981. View

10.

Krishnan A, Swami S, Feldman D . The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer. Steroids. 2012; 77(11):1107-12. PMC: 3429709. DOI: 10.1016/j.steroids.2012.06.005. View

11.

Pittock S, Lucchinetti C . Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci. 2015; 1366(1):20-39. PMC: 4675706. DOI: 10.1111/nyas.12794. View

12.

Grigorian A, Torossian S, Demetriou M . T-cell growth, cell surface organization, and the galectin-glycoprotein lattice. Immunol Rev. 2009; 230(1):232-46. PMC: 3059806. DOI: 10.1111/j.1600-065X.2009.00796.x. View

13.

Desai M, Brinton R . Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Front Endocrinol (Lausanne). 2019; 10:265. PMC: 6501433. DOI: 10.3389/fendo.2019.00265. View

14.

Morrow M, Wingerchuk D . Neuromyelitis optica. J Neuroophthalmol. 2012; 32(2):154-66. DOI: 10.1097/WNO.0b013e31825662f1. View

15.

Kragt J, van Amerongen B, Killestein J, Dijkstra C, Uitdehaag B, Polman C . Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult Scler. 2008; 15(1):9-15. DOI: 10.1177/1352458508095920. View

16.

Li Y, Wang H, Long Y, Lu Z, Hu X . Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis. J Neuroimmunol. 2011; 234(1-2):155-60. DOI: 10.1016/j.jneuroim.2011.03.009. View

17.

Zhang Y, Zhang L, Chen S, Yang G, Huang X, Duan Y . Association between VDR polymorphisms and multiple sclerosis: systematic review and updated meta-analysis of case-control studies. Neurol Sci. 2017; 39(2):225-234. DOI: 10.1007/s10072-017-3175-3. View

18.

Mahon B, Gordon S, Cruz J, Cosman F, Cantorna M . Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol. 2003; 134(1-2):128-32. DOI: 10.1016/s0165-5728(02)00396-x. View

19.

Jarius S, Wildemann B . The history of neuromyelitis optica. J Neuroinflammation. 2013; 10:8. PMC: 3599417. DOI: 10.1186/1742-2094-10-8. View

20.

Mashhadiabbas F, Neamatzadeh H, Nasiri R, Foroughi E, Farahnak S, Piroozmand P . Association of vitamin D receptor BsmI, TaqI, FokI, and ApaI polymorphisms with susceptibility of chronic periodontitis: A systematic review and meta-analysis based on 38 case -control studies. Dent Res J (Isfahan). 2018; 15(3):155-165. PMC: 5958531. View